The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cumulative incidence of financial hardship in metastatic colorectal cancer (mCRC) patients (pts): Primary endpoint results for SWOG S1417CD.
 
Veena Shankaran
Honoraria - Proteus Digital Health; Taiho Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Proteus Digital Health; Taiho Pharmaceutical
 
Joseph M. Unger
No Relationships to Disclose
 
Amy Darke
No Relationships to Disclose
 
Jennifer Marie Suga
No Relationships to Disclose
 
James Lloyd Wade
Employment - Johnson & Johnson (I)
Stock and Other Ownership Interests - Abbott (I); Celgene; GlaxoSmithKline (I); Johnson & Johnson (I); Novartis (I)
Consulting or Advisory Role - New Century Health
 
Peter Kourlas
Stock and Other Ownership Interests - Cornerstone Pharmaceuticals
 
Sreenivasa R Chandana
Honoraria - HERON
Consulting or Advisory Role - Array BioPharma; Dicephera Pharmaceuticals, Inc.; HERON; IPSEN
Speakers' Bureau - Amgen; Eisai; IPSEN; Johnson & Johnson; Novartis
Research Funding - Abbvie (Inst); Alexion Pharmaceuticals (Inst); Alexion Pharmaceuticals (Inst); Alexo Therapeutics (Inst); ArQule (Inst); Asana Biosciences (Inst); Ascentage Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Constellation Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Dicerna (Inst); Formation Biologics (Inst); Forty Seven (Inst); Livzon (Inst); Loxo (Inst); Macrogenics (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Symphony Evolution (Inst); TaiRx, Inc. (Inst)
 
Mark Allen O'Rourke
No Relationships to Disclose
 
Suma Satti
No Relationships to Disclose
 
Diane Liggett
No Relationships to Disclose
 
Dawn L. Hershman
Consulting or Advisory Role - AIM Specialty Health
 
Scott David Ramsey
Employment - Flatiron Health
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Epigenomics; Genentech; GRAIL; Kite, a Gilead company; Merck
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Microsoft (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer Schering Pharma; Bristol-Myers Squibb; Flatiron Health; GRAIL